DNA methylation and mRNA and microRNA expression of SLE CD4+ T cells correlate with disease phenotype

Journal of Autoimmunity

Volumn 54, Issue , 2014, Pages 127-136

  Zhao, Ming ^a   Liu, Siyang ^b   Luo, Shuangyan ^a   Wu, Honglong ^b   Tang, Meini ^a   Cheng, Wenjing ^a   Zhang, Qing ^a   Zhang, Peng ^a   Yu, Xinhai ^a   Xia, Yudong ^b   Yi, Na ^b   Gao, Fei ^b   Wang, Li ^b   Yung, Susan ^c   Chan, Tak Mao ^c   Sawalha, Amr H ^d   Richardson, Bruce ^d   Gershwin, M Eric ^e   Li, Ning ^b   Lu, Qianjin ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b BGI SHENZHEN   (China)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

^d UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

DNA methylation; Epigenetics; MicroRNA; Systemic lupus erythematosus; T cells; Transcriptome

Indexed keywords

CD4 ANTIGEN; MESSENGER RNA; MICRORNA; CD300LB PROTEIN, HUMAN; IMMUNOGLOBULIN RECEPTOR; NLRP2 PROTEIN, HUMAN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; SPHINGOSINE 1 PHOSPHATE RECEPTOR; SPHINGOSINE-1-PHOSPHATE RECEPTOR-3, HUMAN;

ADULT; ARTICLE; AUTOIMMUNITY; CD300LB GENE; CD4+ T LYMPHOCYTE; CELL JUNCTION; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DNA METHYLATION; EPIGENETICS; GENE; GENE OVEREXPRESSION; GENETIC PREDISPOSITION; GENOME ANALYSIS; HIGH THROUGHPUT SEQUENCING; HISTONE MODIFICATION; HUMAN; LEUKOCYTE MIGRATION; NLRP2 GENE; NUCLEOTIDE SEQUENCE; PHENOTYPE; S1PR3 GENE; SKIN DEFECT; SYSTEMIC LUPUS ERYTHEMATOSUS; FEMALE; GENE EXPRESSION REGULATION; IMMUNOLOGY; MALE; PATHOLOGY;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; CD4-POSITIVE T-LYMPHOCYTES; DNA METHYLATION; FEMALE; GENE EXPRESSION REGULATION; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MICRORNAS; RECEPTORS, IMMUNOLOGIC; RECEPTORS, LYSOSPHINGOLIPID; RNA, MESSENGER;

EID: 84908483075     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2014.07.002     Document Type: Article

References (56)

1. Ballestar E., Esteller M., Richardson B.C. The epigenetic face of systemic lupus erythematosus. JImmunol 2006, 176:7143-7147.
2. Meda F., Folci M., Baccarelli A., Selmi C. The epigenetics of autoimmunity. Cell Mol Immunol 2011, 8:226-236.
3. Zhang Y., Zhao M., Sawalha A.H., Richardson B., Lu Q. Impaired DNA methylation and its mechanisms in CD4(+)T cells of systemic lupus erythematosus. JAutoimmun 2013, 41:92-99.
4. Coit P., Jeffries M., Altorok N., Dozmorov M.G., Koelsch K.A., Wren J.D., et al. Genome-wide DNA methylation study suggests epigenetic accessibility and transcriptional poising of interferon-regulated genes in naive CD4+ T cells from lupus patients. JAutoimmun 2013, 43:78-84.
5. Cui Y., Sheng Y., Zhang X. Genetic susceptibility to SLE: recent progress from GWAS. JAutoimmun 2013, 41:25-33.
6. de la Rica L., Urquiza J.M., Gomez-Cabrero D., Islam A.B., Lopez-Bigas N., Tegner J., et al. Identification of novel markers in rheumatoid arthritis through integrated analysis of DNA methylation and microRNA expression. JAutoimmun 2013, 41:6-16.
7. Gonzalez S., Aguilera S., Alliende C., Urzua U., Quest A.F., Herrera L., et al. Alterations in type I hemidesmosome components suggestive of epigenetic control in the salivary glands of patients with Sjogren's syndrome. Arthritis Rheum 2011, 63:1106-1115.
8. Hewagama A., Gorelik G., Patel D., Liyanarachchi P., McCune W.J., Somers E., et al. Overexpression of X-linked genes in T cells from women with lupus. JAutoimmun 2013, 41:60-71.
9. Huber L.C., Stanczyk J., Jungel A., Gay S. Epigenetics in inflammatory rheumatic diseases. Arthritis Rheum 2007, 56:3523-3531.
10. Katoh H., Zheng P., Liu Y. FOXP3: genetic and epigenetic implications for autoimmunity. JAutoimmun 2013, 41:72-78.
11. Lleo A., Oertelt-Prigione S., Bianchi I., Caliari L., Finelli P., Miozzo M., et al. Ychromosome loss in male patients with primary biliary cirrhosis. JAutoimmun 2013, 41:87-91.
12. Lu Q. The critical importance of epigenetics in autoimmunity. JAutoimmun 2013, 41:1-5.
13. Luo Y., Wang Y., Wang Q., Xiao R., Lu Q. Systemic sclerosis: genetics and epigenetics. JAutoimmun 2013, 41:161-167.
14. Ngalamika O., Zhang Y., Yin H., Zhao M., Gershwin M.E., Lu Q. Epigenetics, autoimmunity and hematologic malignancies: a comprehensive review. JAutoimmun 2012, 39:451-465.
15. Pillai S. Rethinking mechanisms of autoimmune pathogenesis. JAutoimmun 2013, 45:97-103.
16. Thabet Y., Le Dantec C., Ghedira I., Devauchelle V., Cornec D., Pers J.O., et al. Epigenetic dysregulation in salivary glands from patients with primary Sjogren's syndrome may be ascribed to infiltrating B cells. JAutoimmun 2013, 41:175-181.
17. Wang Z., Zheng Y., Hou C., Yang L., Li X., Lin J., et al. DNA methylation impairs TLR9 induced Foxp3 expression by attenuating IRF-7 binding activity in fulminant type 1 diabetes. JAutoimmun 2013, 41:50-59.
18. Zhang P., Zhao M., Liang G., Yin G., Huang D., Su F., et al. Whole-genome DNA methylation in skin lesions from patients with psoriasis vulgaris. JAutoimmun 2013, 41:17-24.
19. Zufferey F., Williams F.M., Spector T.D. Epigenetics and methylation in the rheumatic diseases. Semin Arthritis Rheum 2014, 43:692-700.
20. Ball M.P., Li J.B., Gao Y., Lee J.H., LeProust E.M., Park I.H., et al. Targeted and genome-scale strategies reveal gene-body methylation signatures in human cells. Nat Biotechnol 2009, 27:361-368.
21. Singh R.P., Massachi I., Manickavel S., Singh S., Rao N.P., Hasan S., et al. The role of miRNA in inflammation and autoimmunity. Autoimmun Rev 2013, 12:1160-1165.
22. Lu Q., Kaplan M., Ray D., Ray D., Zacharek S., Gutsch D., et al. Demethylation of ITGAL (CD11a) regulatory sequences in systemic lupus erythematosus. Arthritis Rheum 2002, 46:1282-1291.
23. Lu Q., Wu A., Richardson B.C. Demethylation of the same promoter sequence increases CD70 expression in lupus T cells and T cells treated with lupus-inducing drugs. JImmunol 2005, 174:6212-6219.
24. Kaplan M.J., Lu Q., Wu A., Attwood J., Richardson B. Demethylation of promoter regulatory elements contributes to perforin overexpression in CD4+ lupus T cells. JImmunol 2004, 172:3652-3661.
25. Lu Q., Wu A., Tesmer L., Ray D., Yousif N., Richardson B. Demethylation of CD40LG on the inactive X in T cells from women with lupus. JImmunol 2007, 179:6352-6358.
26. Absher D.M., Li X., Waite L.L., Gibson A., Roberts K., Edberg J., et al. Genome-wide DNA methylation analysis of systemic lupus erythematosus reveals persistent hypomethylation of interferon genes and compositional changes to CD4+ T-cell populations. PLoS Genet 2013, 9:e1003678.
27. Jeffries M.A., Dozmorov M., Tang Y., Merrill J.T., Wren J.D., Sawalha A.H. Genome-wide DNA methylation patterns in CD4+ T cells from patients with systemic lupus erythematosus. Epigenetics 2011, 6:593-601.
28. Amarilyo G., La Cava A. miRNA in systemic lupus erythematosus. Clin Immunol 2012, 144:26-31.
29. Miao C.G., Yang Y.Y., He X., Huang C., Huang Y., Zhang L., et al. The emerging role of microRNAs in the pathogenesis of systemic lupus erythematosus. Cell Signal 2013, 25:1828-1836.
30. Shen N., Liang D., Tang Y., de Vries N., Tak P.P. MicroRNAs-novel regulators of systemic lupus erythematosus pathogenesis. Nat Rev Rheumatol 2012, 8:701-709.
31. Zhao S., Wang Y., Liang Y., Zhao M., Long H., Ding S., et al. MicroRNA-126 regulates DNA methylation in CD4+ T cells and contributes to systemic lupus erythematosus by targeting DNA methyltransferase 1. Arthritis Rheum 2011, 63:1376-1386.
32. Pan W., Zhu S., Yuan M., Cui H., Wang L., Luo X., et al. MicroRNA-21 and microRNA-148a contribute to DNA hypomethylation in lupus CD4+ T cells by directly and indirectly targeting DNA methyltransferase 1. JImmunol 2010, 184:6773-6781.
33. Dooley M.A., Aranow C., Ginzler E.M. Review of ACR renal criteria in systemic lupus erythematosus. Lupus 2004, 13:857-860.
34. Tan E.M., Cohen A.S., Fries J.F., Masi A.T., McShane D.J., Rothfield N.F., et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982, 25:1271-1277.
35. Hahn B.H., McMahon M.A., Wilkinson A., Wallace W.D., Daikh D.I., Fitzgerald J.D., et al. American college of rheumatology guidelines for screening, treatment, and management of lupus nephritis. Arthritis Care Res Hob 2012, 64:797-808.
36. Li L.C., Dahiya R. MethPrimer: designing primers for methylation PCRs. Bioinformatics 2002, 18:1427-1431.
37. Blackledge N.P., Klose R. CpG island chromatin: a platform for gene regulation. Epigenetics 2011, 6:147-152.
38. Deaton A.M., Bird A. CpG islands and the regulation of transcription. Genes Dev 2011, 25:1010-1022.
39. Kirou K.A., Lee C., George S., Louca K., Peterson M.G., Crow M.K. Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease. Arthritis Rheum 2005, 52:1491-1503.
40. Ding S., Liang Y., Zhao M., Liang G., Long H., Zhao S., et al. Decreased microRNA-142-3p/5p expression causes CD4+ T cell activation and B cell hyperstimulation in systemic lupus erythematosus. Arthritis Rheum 2012, 64:2953-2963.
41. Bartel D.P. MicroRNAs: target recognition and regulatory functions. Cell 2009, 136:215-233.
42. Docherty S.J., Davis O.S., Haworth C.M., Plomin R., Mill J. Bisulfite-based epityping on pooled genomic DNA provides an accurate estimate of average group DNA methylation. Epigenetics Chromatin 2009, 2:3.
43. Toperoff G., Aran D., Kark J.D., Rosenberg M., Dubnikov T., Nissan B., et al. Genome-wide survey reveals predisposing diabetes type 2-related DNA methylation variations in human peripheral blood. Hum Mol Genet 2012, 21:371-383.
44. Abd-Elkareem M.I., Al Tamimy H.M., Khamis O.A., Abdellatif S.S., Hussein M.R. Increased urinary levels of the leukocyte adhesion molecules ICAM-1 and VCAM-1 in human lupus nephritis with advanced renal histological changes: preliminary findings. Clin Exp Nephrol 2010, 14:548-557.
45. Cheng Q., Hoi A., Hickey M.J., Morand E.F. Lymphocytes from systemic lupus erythematosus patients display increased spreading on VCAM-1, an effect associated with active renal involvement. Lupus 2012, 21:632-641.
46. Norman M.U., James W.G., Hickey M.J. Differential roles of ICAM-1 and VCAM-1 in leukocyte-endothelial cell interactions in skin and brain of MRL/faslpr mice. JLeukoc Biol 2008, 84:68-76.
47. Perl A. Oxidative stress in the pathology and treatment of systemic lupus erythematosus. Nat Rev Rheumatol 2013, 9:674-686.
48. Kucukali C.I., Kurtuncu M., Coban A., Cebi M., Tuzun E. Epigenetics of multiple sclerosis: an updated review. Neuromolecular Med 2014, 10.1007/s12017-014-8298-6.
49. Lupfer C., Kanneganti T.D. Unsolved mysteries in NLR biology. Front Immunol 2013, 4:285.
50. Fontalba A., Gutierrez O., Fernandez-Luna J.L. NLRP2, an inhibitor of the NF-kappaB pathway, is transcriptionally activated by NF-kappaB and exhibits a nonfunctional allelic variant. JImmunol 2007, 179:8519-8524.
51. Bhattacharjee P., Das N., Chatterjee D., Banerjee A., Das J.K., Basu S., et al. Association of NALP2 polymorphism with arsenic induced skin lesions and other health effects. Mutat Res 2013, 755:1-5.
52. Minkiewicz J., de Rivero Vaccari J.P., Keane R.W. Human astrocytes express a novel NLRP2 inflammasome. Glia 2013, 61:1113-1121.
53. Yang X.L., Hu Z.D., Wu Q., Liu X., Liu Q.J., Zhang Y.C., et al. Association of polymorphisms in SPARC and NLRP2 genes with rheumatoid arthritis in a Chinese Han population. Mod Rheumatol 2014, 10.3109/14397595.2014.903595.
54. Gasiorowski R.E., Ju X., Hart D.N., Clark G.J. CD300 molecule regulation of human dendritic cell functions. Immunol Lett 2013, 149:93-100.
55. Yamanishi Y., Takahashi M., Izawa K., Isobe M., Ito S., Tsuchiya A., et al. Asoluble form of LMIR5/CD300b amplifies lipopolysaccharide-induced lethal inflammation in sepsis. JImmunol 2012, 189:1773-1779.
56. Hamidi S., Schafer-Korting M., Weindl G. TLR2/1 and sphingosine 1-phosphate modulate inflammation, myofibroblast differentiation and cell migration in fibroblasts. Biochim Biophys Acta 2014, 1841:484-494.